Evidence-based rheumatology practice

Current Opinion in Rheumatology

Volumn 17, Issue 2, 2005, Pages 117-123

  Krishnan, Laura L ^b   Suarez Almazor, Maria E ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Evidence based medicine; Professional practice; Rheumatic diseases; Rheumatology

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; HYALURONIC ACID; INFLIXIMAB; METHOTREXATE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; VALDECOXIB;

ANKYLOSING SPONDYLITIS; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; LOW DRUG DOSE; META ANALYSIS; OSTEOARTHRITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SIDE EFFECT; TAI CHI;

EVIDENCE-BASED MEDICINE; HUMANS; PROFESSIONAL PRACTICE; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 14044268181     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000154201.49338.f6     Document Type: Review

References (58)

1. Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ 1995; 310:1122-1126.
2. Andrews EJ, Redmond HP. A review of clinical guidelines. Br J Surg 2004; 91:956-964.
3. Stocks G, Dennis D, Mesko JW, et al. AAOS clinical practice guideline on osteoarthritis of the knee (phases I & II). American Academy of Orthopaedic Surgeons. Updated October 2003. http://www.aaos.org. [Accessed 4 September 2004]
4. Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62:1145-1155. Important updated evidenced-based recommendations encompassing 545 publications presenting 10 recommendations for treatment of knee osteoarthritis and 10 critical items for future research.
5. Roddy E, Zhang W, Doherty M, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee: the MOVE consensus. Rheumatology (Oxford) 2004; 44:67-73. The first set of recommendations for exercise in knee and hip osteoarthritis. It also identifies areas for further study.
6. Lee J, Thorson D, Jurrison M, et al. Health care guideline: diagnosis and treatment of adult degenerative joint disease (DJD) of the knee. Institute for Clinical Systems Improvement. Updated November 2003. http://www.icsi.org. [Accessed 4 September 2004]
7. Thorson DC, Campbell R, Kuku O, et al. Health care guideline: adult low back pain. Institute for Clinical Systems Improvement. Updated September 2004. http://www.icsi.org. [Accessed 7 October 2004] A comprehensive guideline for the management of chronic and acute low back pain, including a treatment algorithm, screening tools, and a discussion of the evidence.
8. Simonelli C, Clarke B, Cohan D, et al. health care guideline: diagnosis and treatment of osteoporosis. Institute for Clinical Systems Improvement. Updated July 2004. http://www.icsi.org. [Accessed 7 October 2004] A comprehensive guideline for the diagnosis and treatment of osteoporosis, including a treatment algorithm, a health education handout, and a discussion of the evidence.
9. Braun J, Pham T, Sieper J, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003; 62:817-824. Presents a new international consensus intended to guide rheumatologists on the use of antitumor necrosis factor agents in treating patients with ankylosing spondylitis.
10. Gotzsche P, Johansen H. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 2004; 3:CD000189.
11. Wienecke T, Gotzsche PC. Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev 2004; 3:CD003789. Review.
12. Stone M, Fortin PR, Pacheco-Tena C, Inman RD. Should tetracycline treatment be used more extensively for rheumatoid arthritis? metaanalysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol 2003; 30:2112-2122.
13. Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 2003; 62(Suppl 2):ii13-ii16. A systematic review that uses adjusted indirect comparisons to examine response to the three biologic agents across RCTs.
14. Clark W, Jobanputra P, Barton P, Burls A. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. Health Technol Assess 2004; 8:iii-x, 1.
15. Steultjens EM, Dekker J, Bouter LM, et al. Occupational therapy for rheumatoid arthritis. Cochrane Database Syst Rev 2004; 3:CD003114.
16. Han A, Robinson V, Judd M, et al. Tai chi for treating rheumatoid arthritis. Cochrane Database Syst Rev 2004; 3:CD004849.
17. Wessel J. The effectiveness of hand exercises for persons with rheumatoid arthritis: a systematic review. J Hand Ther 2004; 17:174-180.
18. Niedermann K, Fransen J, Knols R, Uebelhart D. Gap between short- and long-term effects of patient education in rheumatoid arthritis patients: a systematic review. Arthritis Rheum 2004; 51:388-398. This article examines seven different RCTs of educational interventions, evaluating methodological quality and focusing on long-term effects.
19. Pattison DJ, Harrison RA, Symmons DP. The role of diet in susceptibility to rheumatoid arthritis: a systematic review. J Rheumatol 2004; 31:1310-1319.
20. Wilson A, Yu HT, Goodnough LT, Nissenson AR. Prevalence and outcomes of anemia in rheumatoid arthritis; a systematic review of the literature. Am J Med 2004; 116 (Suppl 7A):50S-57S.
21. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003; 290:3115-3121. An important meta-analysis of 22 RCTs of hyaluronic acid compared with placebo injection, which includes an examination for possible publication bias along with its conclusions about efficacy.
22. Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004; 86:538-545.
23. Aggarwal A, Sempowski IP. Hyaluronic acid injections for knee osteoarthritis: systematic review of the literature. Can Fam Physician 2004; 50:249-256.
24. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 2004; 328:869.
25. Godwin M, Dawes M. Intra-articular steroid injections for painful knees: systematic review with meta-analysis. Can Fam Physician 2004; 50:241-248.
26. Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 2004; 5:28.
27. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis; meta-analysis of randomised controlled trials. BMJ 2004; 329:324. A meta-analysis intended to determine the benefit of NSAIDs in treating osteoarthritis for periods of time longer than 2 weeks, given that a previous review found NSAIDs effective for short-term use.
28. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? a meta-analysis of randomised controlled trials. Ann Rheum Dis 2004,63:901-907. This article presents the results of a meta-analysis examining the efficacy of paracetamol, which has recently been questioned in comparison with other alternatives, compared with that of NSAIDs.
29. Edwards JE, McQuay HJ, Moore RA. Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis; systematic review of randomised controlled trials. Pain 2004; 111:286-296.
30. Heintjes E, Berger M, Bierma-Zeinstra S, et al. Pharmacotherapy for patellofemoral pain syndrome. Cochrane Database Syst Rev 2004; 3:CD003470.
31. Brosseau L, Welch V, Wells G, et al. Low level laser therapy (classes I, II and III) for treating osteoarthritis. Cochrane Database Syst Rev 2004; 3:CD002046.
32. McDonald S, Hetrick S, Green S. Pre-operative education for hip or knee replacement. Cochrane Database Syst Rev 2004; 3:CD003526.
33. Jolles BM, Bogoch ER. Surgical approach for total hip arthroplasty: direct lateral or posterior? J Rheumatol 2004; 31:1790-1796.
34. Martou G, Veltri K, Thoma A. Surgical treatment of osteoarthritis of the carpometacarpal joint of the thumb: a systematic review. Plast Reconstr Surg 2004; 114:421-432.
35. Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis: a systematic review. Clin Rheumatol 2003; 22:285-288.
36. Yelland MJ, Del MC, Pirozzo S, Schoene ML. Prolotherapy injections for chronic low back pain. Cochrane Database Syst Rev 2004; 3:CD004059.
37. Shea B, Wells G, Cranney A, et al. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 2004; 3:CD004526.
38. Falkenbach A, Kovacs J, Franke A, et al. Radon therapy for the treatment of rheumatic diseases-review and meta-analysis of controlled clinical trials. Rheumatol Int 2003 (Epub ahead of print).
39. van Dijk MA, Reitsma JB, Fischer JC, Sanders GT. Indications for requesting laboratory tests for concurrent diseases in patients with carpal tunnel syndrome: a systematic review. Clin Chem 2003; 49:1437-1444.
40. Yazici Y, Erkan D, Paget SA. Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events. Arthritis Rheum 2003; 48:2769-2772. This noteworthy study presents the results of a survey of American College of Rheumatology members to examine current opinions and practices related to monitoring protocols for methotrexate and biologic agents, which is of particular importance because of the current lack of monitoring guidelines for biologic agents.
41. Fransen J, Laan RF, Van Der Laar MA, et al. Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis. Ann Rheum Dis 2004; 63:1222-1226. Presents findings on the effect of guideline adherence on the safety and efficacy of methotrexate.
42. Samanta A, Goh L, Bawendi A. Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? a nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance. Rheumatology (Oxford) 2004; 43:346-348. A cross-sectional survey of British rheumatologists that identifies a lack of compliance with national ocular monitoring guidelines for patients on hydroxycholoroquine.
43. Charalambous CP, Tryfonidis M, Sadiq S, et al. Septic arthritis following intra-articular steroid injection of the knee: a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee. Clin Rheumatol 2003; 22:386-390. This survey of British rheumatologists, orthopedic surgeons, and general practitioners identifies the need for improved antiseptic techniques with this procedure, although septic arthritis following steroid injection of the knee appears to be rare.
44. Feldstein AC, Nichols GA, Elmer PJ, et al. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am 2003; 85:2294-2302. A study concluding that adherence to guidelines for the prevention and treatment of osteoporosis did not improve from 1998 to 2001, in spite of the existence of clinical practice guidelines.
45. MacLean CH, Saag KG, Solomon DH, et al. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004; 51:193-202. Presents crucial sets of quality indicators for rheumatoid arthritis, osteoarthritis, and analgesic use, and the methods used for deriving them, based on the scientific evidence and expert consensus.
46. Pencharz JN, MacLean CH. Measuring quality in arthritis care: the Arthritis Foundation's Quality Indicator set for osteoarthritis. Arthritis Rheum 2004; 51:538-548. Presents the comprehensive set of 14 quality indicators for osteoarthritis in detail, including supporting evidence for use in assessing the quality of care for osteoarthritis.
47. Saag KG, Olivieri JJ, Patino F, et al. Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics. Arthritis Rheum 2004; 51:337-349.
48. Jacobi CE, Boshuizen HC, Rupp I, et al. Quality of rheumatoid arthritis care; the patient's perspective. Int J Qual Health Care 2004; 16:73-81.
49. Jacobi CE, Rupp I, Boshuizen HC, et al. Unmet demands for health care among patients with rheumatoid arthritis: indications for underuse? Arthritis Rheum 2004; 51:440-446. This survey of 679 patients with rheumatoid arthritis identifies areas of health care in which patient demands are not being met and areas in which health care is underused.
50. Kremers HM, Bidaut-Russell M, Scott CG, et al. Preventive medical services among patients with rheumatoid arthritis. J Rheumatol 2003; 30:1940-1947.
51. Victor CR, Ross F, Axford J. Capturing lay perspectives in a randomized control trial of a health promotion intervention for people with osteoarthritis of the knee. J Eval Clin Pract 2004; 10:63-70.
52. Li LC, Maetzel A, Pencharz JN, et al. Use of mainstream nonpharmacologic treatment by patients with arthritis. Arthritis Rheum 2004; 51: 203-209.
53. Mikuls TR, MacLean CH, Olivieri J, et al. Quality of care indicators for gout management. Arthritis Rheum 2004; 50:937-943. Presents a set of 10 quality of care indicators for management of gout, derived from a review of the literature and expert evaluation.
54. Chodosh J, Solomon DH, Roth CP, et al. The quality of medical care provided to vulnerable older patients with chronic pain. J Am Geriatr Soc 2004; 52:756-761.
55. Newman ED, Harrington TM, Olenginski TP, et al. 'The rheumatologist can see you now': successful implementation of an advanced access model in a rheumatology practice. Arthritis Rheum 2004; 51:253-257. This article presents an innovative model to help measure and eliminate backlog in rheumatology practice that was able to improve access and patient satisfaction.
56. Lin EH, Katon W, Von KM, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003; 290:2428-2429. This is the first RCT to assess the effect of improving treatment for comorbid depression among primary care patients with arthritis. It finds that improving treatment of depression improves pain, functional status, quality of life, and depressive symptoms.
57. Solomon DH, Avorn J, Warsi A, et al. Which patients with knee problems are likely to benefit from nonarthroplasty surgery? development of a clinical prediction rule. Arch Intern Med 2004; 164:509-513. This study presents a clinical prediction rule, based on a series of 103 patients and the expert opinions of orthopedic surgeons, that identifies patients likely to benefit from nonarthroplasty surgery in view of accessible characteristics.
58. Conner-Spady BL, Arnett G, McGurran JJ, Noseworthy TW. Prioritization of patients on scheduled waiting lists: validation of a scoring system for hip and knee arthroplasty. Can J Surg 2004; 47:39-46.